Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
12.67
-0.07 (-0.55%)
Mar 9, 2026, 1:28 PM EDT - Market open
Schrödinger Revenue
In the year 2025, Schrödinger had annual revenue of $255.87M with 23.29% growth. Schrödinger had revenue of $87.24M in the quarter ending December 31, 2025, a decrease of -1.23%.
Revenue (ttm)
$255.87M
Revenue Growth
+23.29%
P/S Ratio
3.55
Revenue / Employee
$301,022
Employees
850
Market Cap
935.36M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.53B |
| Evolent Health | 1.88B |
| Omnicell | 1.18B |
| GoodRx Holdings | 796.85M |
| Phreesia | 463.21M |
| Certara | 418.84M |
| HealthStream | 304.06M |
| Omada Health | 260.21M |
SDGR News
- 3 days ago - Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 11 days ago - Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results - Business Wire
- 13 days ago - Schrödinger to Participate in Upcoming Investor Conferences - Business Wire
- 18 days ago - Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1 - Benzinga
- 19 days ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 26 days ago - Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - Business Wire
- 2 months ago - Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities - Business Wire